14 | TAUG Stock Charts Last: +0.005 Saturday, March 1, | chartguy89 | 03/01/2014 10:37:32 PM |
13 | OUCH Recent 10Q | goarmy123 | 10/10/2012 11:44:37 PM |
12 | I am gonna try to get in before the am gap! Looks | goarmy123 | 10/10/2012 9:29:07 PM |
11 | $IMUN news letters rolling in the mail | goarmy123 | 10/10/2012 9:18:47 PM |
10 | $IMUN Research report! | goarmy123 | 10/10/2012 8:35:10 PM |
9 | $IMUN Insiders bought on the 5th and the 9th of | goarmy123 | 10/10/2012 8:26:20 PM |
8 | $IMUN | goarmy123 | 10/10/2012 8:24:59 PM |
7 | $IMUN | goarmy123 | 10/10/2012 7:55:30 PM |
6 | $IMUN News links. | goarmy123 | 10/10/2012 7:53:53 PM |
5 | $IMUN is rated a strong buy per bar charts! | goarmy123 | 10/10/2012 7:52:24 PM |
4 | $IMUN Insiders buying shares this month at | goarmy123 | 10/10/2012 7:43:44 PM |
3 | $IMUN Insider buys! QB Filings. | goarmy123 | 10/10/2012 7:42:55 PM |
2 | $IMUN News letter. | goarmy123 | 10/10/2012 7:38:08 PM |
1 | PEEKING IN HERE! | goarmy123 | 10/10/2012 6:31:16 PM |
Recent Articles
- Important Legal Steps for Neogen Corporation Investors
- Barbara Corcoran Shares Insights on Trump's Sales Tactics
- Luminar Technologies Faces Lawsuit: Investors Take Action
- Navigating the Potential of RxSight Securities Lawsuit
- Stock Market Analysis: Insight into Current Trends and Highlights
- Understanding the Class Action Lawsuit Against RxSight, Inc.
- Faruqi & Faruqi LLP Takes on Altimmune Securities Fraud Case
- PepGen Investors Advised on Class Action Lawsuit Opportunities
- Important Class Action Update for Replimune Investors
- Investor Alert: Rocket Pharmaceuticals Class Action Details
- Faruqi & Faruqi Calls Investors to Act on Sable Offshore Case
- Fluor Corporation: Scrutiny Over Securities Misleading Claims
- Apple Inc. Faces Legal Challenges Over Investor Trust Issues
- Investors Urged to Act in Petco Class Action Lawsuit - WOOF
- IRS Leadership Shake-Up: Scott Bessent Steps In Amid Change
- US Air Force Utilizes Tesla Cybertrucks for Combat Simulations
- Magid Gloves Recognized as Industry Leaders in Safety Gear
- Learning from the Dotcom Era: Investing in Quality Stocks
- Mastering Price Breakouts: Avoid Common Trading Pitfalls
- Elon Musk and Bill Gates: A Stark Contrast in Wealth Fluctuations
- Trade Desk Faces Major Challenges as Amazon's Ad Business Soars
- Xauras Emerges as a Leader in the DeFi Lending Revolution
- Financial Market Turbulence: Gold Tariffs and Earnings Impact
- SALOMON Launches Unique Concept Store to Boost Retail in China
- Tesla Launches Robotaxi Service in Texas, Competing with Uber
- RoboSense Unveils Groundbreaking Active Camera at Robotics Event
- Tegna's Stock Surges Amid Nexstar Acquisition Talks
- India's Shift in Defense Strategy: Delays and Implications
- Design a Workshop That Stays Safe, Efficient, and Flexible
- Apple's Leadership Challenge in AI: A Crucial Turning Point
- Texas Attorney General's Battle Against Democratic Defiance
- Folqs Launches First-Day Colostrum Powder to Meet Rising Demand
- AONMeetings Introduces Affordable Webinar Solutions for All
- Neogen Corporation Investors Alert: Class Action Update Received
- Investor Update: Hims & Hers Issues Legal Notice for Shareholders
- Sable Offshore Investors: Act Now to Protect Your Rights
- Investors Urged to Act: Flywire Corporation Class Action Update
- Nvidia's H20 Chip Exports to China: A Pivotal Opportunity
- Discover the Legacy of Savoy with Engaging Lecture Series
- Upcoming Trump-Putin Summit in Alaska Sparks Market Activity
- Elegoo Introduces Innovative Creator Fund to Support 3D Design
- Elegoo Unveils Groundbreaking Creator Fund for Innovators
- America's Progress Under President Trump's Leadership Explored
- Legal Proceedings Update for Sarepta Therapeutics Investors
- America's Bright Future: A Look at Trump's Recent Achievements
- Uncovering the Lawsuit against Sable Offshore Corp: SOC Investors
- Anbio Biotechnology Innovates Rapid Testing for Outbreaks
- Exploring the Heritage of the Savoy Lecture Series Events
- Columbia University Faces Legal Action After Major Data Breach
- Understanding Your Rights in Altimmune, Inc. Class Action